Vertical and Horizontal Mandibular Ridge Augmentation Techniques

July 21, 2025 updated by: Hom-Lay Wang, DDS, MSD, Ph D, University of Michigan

Vertical and Horizontal Mandibular Ridge Augmentation Techniques: A Randomized Controlled Clinical Trial Comparing Customized CAD/CAM Titanium Mesh Versus Reinforced Perforated PTFE Mesh

The purpose of this study is to compare alveolar ridge augmentation outcomes of two types of membranes for vertical and horizontal mandibular ridge augmentation: Customized CAD/CAM Titanium Mesh versus Reinforced Perforated PTFE Mesh (RPM).

Study Overview

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • University of Michigan School of Dentistry

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age ≥ 18 years
  • Physical status according to the American Society of Anesthesiology (ASA) I or II, which includes patients who are systematically healthy or may suffer from mild to moderate, however well-controlled systemic diseases.
  • Subjects having at least one free end saddle edentulous area of the posterior area of the mandible with moderate horizontal and vertical bone defects >≥3mm.
  • Capacity to understand and accept the written conditions of the study.

Exclusion Criteria:

  • Insufficient oral hygiene.
  • Smoking habit of >10 cigarettes/day (self-reported).
  • Abuse of alcohol or drugs.
  • Pregnancy or individuals attempting to get pregnant (self-reported).
  • Acute local or systemic infections.
  • Uncontrolled diabetes or other metabolic disease.
  • Severe hepatic or renal dysfunction.
  • Autoimmune disorders.
  • Patients who underwent radiotherapy in the last 5 years.
  • Patients undergoing immunosuppressive therapy or who are immunocompromised.
  • Any other contraindications for undergoing surgery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Customized CAD/CAM Titanium Mesh
A customized CAD/CAM Titanium Mesh will be used to cover the bone graft
A composite graft composed of a 50:50 proportion of autogenous bone and a demineralized bone mineral will be positioned around the bony defect or placed in the membrane, depending on the group randomization. The selected membrane will then be secured with screws to ensure a complete and stable coverage of the grafted area.
Active Comparator: Reinforced Perforated PTFE Mesh (RPM)
A Reinforced Perforated PTFE Mesh membrane will be used to cover the bone graft
A composite graft composed of a 50:50 proportion of autogenous bone and a demineralized bone mineral will be positioned around the bony defect or placed in the membrane, depending on the group randomization. The selected membrane will then be secured with screws to ensure a complete and stable coverage of the grafted area.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ridge width changes in mm
Time Frame: 6 months
Radiographic changes of the ridge width based on cone-beam computed tomography (CBCT) scan measurements
6 months
Ridge height changes in mm
Time Frame: 6 months
Radiographic changes of the ridge width based on cone-beam computed tomography (CBCT) scan measurements
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Histological outcomes of the augmented bone
Time Frame: 6 months
In terms of the amount of newly formed vital bone, residual graft particles, and connective tissue (CT)/other non-mineralized tissue components as a percentage
6 months
The volumetric bone gain of the grafted area in mm3
Time Frame: 6 months
Radiographic changes of bone volume based on cone-beam computed tomography (CBCT) scan measurements
6 months
Rate of complications
Time Frame: 6 months
Percentage that had complications associated with each technique
6 months
Cost analysis
Time Frame: 6 months
Difference in cost-effectiveness in dollars
6 months
Change in the mucosal thickness in mm
Time Frame: 6 months
Change in the mucosal thickness due to the provided space from baseline to the surgical mesh removal using an ultrasound
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hom-Lay Wang, DDS MSD PhD, Department of Periodontics and Oral Medicine, University of Michigan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 1, 2025

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

June 1, 2027

Study Registration Dates

First Submitted

October 8, 2024

First Submitted That Met QC Criteria

October 8, 2024

First Posted (Actual)

October 10, 2024

Study Record Updates

Last Update Posted (Actual)

July 25, 2025

Last Update Submitted That Met QC Criteria

July 21, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • HUM00262750

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Horizontal Ridge Deficiency

Clinical Trials on Guided bone regeneration (GBR)

Subscribe